Monepantel

DRUG2 trials

Sponsors

Neurizon Therapeutics Limited

Conditions

Motor Neuron Disease

Phase 1

A Study of Monepantel in Individuals With Motor Neurone Disease

CompletedNCT04894240

Neurizon Therapeutics LimitedMotor Neuron Disease

Start: 2022-06-28End: 2023-11-29Updated: 2023-12-21

An Open Label Extension Study of Monepantel in Individuals With Motor Neurone Disease

CompletedNCT06177431

Neurizon Therapeutics LimitedMotor Neuron Disease

Start: 2024-02-13End: 2025-05-30Updated: 2025-06-04